Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Breast screening programme to be reviewed

  • 1 Comment

Many news sources have reported that a “major review” of the NHS breast screening programme is to take place. BBC News said “the evidence for breast cancer screening in the UK is being reviewed amid controversy about the measure’s effectiveness”.

The news of the review comes from Professor Sir Mike Richards, national cancer director at the Department of Health, who discusses it in an open letter in the BMJ. It follows criticism of the current screening programme by some doctors who believe that by throwing up some false results, screening may be doing more harm than good.

The majority of specialists in the field are thought to support the current breast screening programme. However, Richards said: “Should the independent review conclude that the balance of harms outweighs the benefits of breast screening, I will have no hesitation in referring the findings to the UK National Screening Committee and then ministers.”

What has prompted this review?

Professor Richards announced the review in response to debate among scientists over the effectiveness of breast screening. For example, a recent Cochrane Collaboration review of breast screening concluded that “it was not clear whether screening does more good than harm”.

The three highest-quality studies covered by the review showed that screening did not significantly reduce death from breast cancer after 13 years in comparison to women who weren’t screened. However, lower-quality studies showed a significant reduction in breast cancer death in those who were screened.

When the high- and lower-quality studies were combined, the overall effect showed screening did reduce the relative risk of breast cancer death by 13-26%. The authors highlighted that the lower-quality studies may be biased to favour screening, and estimated the true relative reduction in death from breast cancer due to screening to be in the region of 15%.

What are the pros and cons of breast screening?

There has always been debate about the pros and cons of screening, revolving around the complex balance of its benefits and harms.

The benefit of screening is in finding breast cancer at an early stage when there is a good chance of successful treatment and full recovery. The drawback, however, is that screening will also result in some women being over-diagnosed - receiving a diagnosis of cancer that would not have led to death or sickness. Currently, it is not possible to tell who these women are, and they are therefore likely to have breasts or lumps removed and to receive unnecessary radiotherapy. The investigations, such as a biopsy, needed to reach a firm diagnosis can also cause harm.

Different research studies and reviews have produced different figures for the relative number of women who benefit from screening versus those potentially harmed. Hence, it is difficult to establish exactly how accurate the current screening programme is.

What is the breast screening programme?

The NHS Breast Screening Programme screens around 1.6million women a year. Women aged 50 to 70 years of age, who are registered with a GP, are automatically invited for screening every three years. In 2012, an extension to the programme is being introduced by conducting a large trial where women aged between 47 and 73 will be invited to take part in the study.

Screening takes place at a special clinic or mobile breast screening unit where a mammogram (X-ray of the breast) is taken by a female health professional. This is then studied to look for any abnormalities. The aim is to find breast cancer at an early stage, when any changes in the breast would be too small to feel and when there is a good chance of successful treatment and full recovery.

The main treatments for breast cancer are surgery (removing a lump or the entire breast), radiotherapy, chemotherapy, hormone therapy and biological therapy. Patients may have one of these treatments or a combination.

How will the review be carried out?

The independent review will be led by Professor Richards and Harpal Kumar, chief executive at Cancer Research UK. Professor Richards says they are seeking independent advisers for the review who have never previously published on the topic of breast cancer screening. The letter did not give any indication of how long the review might take.

  • 1 Comment

Readers' comments (1)

  • This review also needs to consider access to the Breast Cancer Screening Programme.

    Access to breast cancer screening needs attention i.e allow women to attend a screening centre of their choice in the location that best fits in with their work, caring and family commitments. At the moment there is no choice of centre at all - you can only go to the designated screening centre on your own"patch" or not be screened at all i.e take it or leave it!

    This is especially important to women in rural areas such as Devon where women are only allowed to attend the screening centres on their own "patch", even when there is a screening centre just up the road from them,but which is in a different "patch" which they are not allowed to attend.

    In Devon, the East Devon and West Devon screening co-ordinators need to urgently review their access criteria so that women in Devon are free to use whichever centre is easiest for them - and preferably include Cornwall in any such new arrangements, to ensure maximum flexibility across the peninsula.

    Access to screening centres for women living in rural areas is difficult enough for those who can drive, it's almost impossible for those who are dependant on rural public transport and simply dont have the time or money to spare to do a "day-trip" to the breast screening centre on very limited rural bus services.

    Patient Choice needs to be urgently extended to the Breast Screening Service, so that women can attend the most convenient centre for them. That is a simple and practical way to improve uptake, especially from women who are struggling to cope financially and who simply cannot afford long journeys, and those who are juggling their time on a daily basis to care for other family members.

    I hope someone responsible for the breast screening programme and/or cancer service improvement will pick up and action these suggestions.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.